Christopher Ruane explains how, by buying FTSE 100 shares at what he thinks are bargain prices, he hopes to build wealth over years to come.

This complaint was first surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign ...

Alzheimer’s disease could be diagnosed up to a decade earlier after the world’s biggest study of proteins is completed. The ...

Fort Myers-based cancer lab NeoGenomics is getting a new CEO. Tony Zook, an independent board member, will assume the role.

AstraZeneca PLC AZN shares inched down 0.05% to £109.82 Friday, on what proved to be an all-around dismal trading session for ...

MI-HQ will anchor Dan Gilbert’s Bedrock development at the former “fail jail” site on Gratiot Avenue in downtown Detroit with ...

A groundbreaking study analyzing how levels of up to 5,400 proteins circulating in our body change in mid-to-late life and ...

A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...

A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...

Daiichi Sankyo's stock dropped 25% due to disappointing clinical data, but upcoming studies could drive a rebound for ...

New treatments like dotinurad provide safer, more effective solutions for millions battling gout and hyperuricemia.

If you suffered losses exceeding $100,000 in AstraZeneca between between February 23, 2022 and December 17, 2024 and would ...